Optcom Twitter RSS and Email Facebook
social icons_160
Marco
AcuityPro
Sigma Pharmaceuticals,  LLC
Biosyntrx
RevolutionEHR
07
Nov

Intravitreal implant may pose risk of increased IOP

Posted by Walt Mayo, OD
Walt Mayo, OD
Optcom Founder
User is currently offline
in Research
Source: osnsupersite.com 

Q\Patients receiving a fluocinolone acetonide intravitreal implant for noninfectious uveitis had a significantly high risk for increased IOP that often necessitated surgical intervention, a study found. 

http://bit.ly/vGik5x
0 votes
Tags: Untagged

Comments

Please login first in order for you to submit comments
Newsletter
Digest
Listserv
Vancouver


AcuityPro


New Issue